CCL2 and atherosclerosis: Apart from the above mentioned receptors, chemokine CCL2/MCP-1 is a critical mediator of atherosclerosis, and the absence of MCP-1 has been shown to reduce atherosclerosis in low-density lipoprotein receptor-deficient mice (Gu et al., 1998).